Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 150 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
177Lu-PSMA-617 for metastatic castrationresistant prostate cancer - third line	Lutetium (177Lu-PSMA-617; 177Lu-DOTA-tyr3-octreotate; Lutathera)	Prostate cancer	Male Reproductive Cancer	2020	View \| Download
ABBV-951 for motor fluctuations in Parkinson’s disease	ABBV-951 (fixed dose combination: Carbidopa; Levodopa)	Parkinson's disease	Neurology	2020	View \| Download
Abemaciclib for early breast cancer – adjuvant treatment	Abemaciclib (LY2835219; Verzenio; CC-115)	Breast cancer	Breast Cancer	2020	View \| Download
Abilify MyCite (aripiprazole with sensor) for bipolar disorder and schizophrenia	Aripiprazole (Abilify Mycite; Abilify; OPC-14597; Aristada; ALKS-9070)	Bipolar disorder , Schizophrenia	Mental and Behavioural Health	2020	View \| Download
Abrocitinib for moderate to severe atopic dermatitis	Abrocitinib (PF-04965842)	Atopic dermatitis	Dermatology	2020	View \| Download
Aducanumab for mild cognitive impairment due to Alzheimer’s disease	Aducanumab (BIIB037)	Cognitive impairment	Neurology	2020	View \| Download
AMG 510 for KRAS G12c mutated metastatic non-small cell lung cancer - after prior standard therapy	Sotorasib (AMG 510)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2020	View \| Download
Anifrolumab for moderately to severly active, autoantibody-positive systemic lupus erythematosus	Anifrolumab (MEDI546)	Systemic lupus erythematosus (SLE)	Immunology , Nephrology	2020	View \| Download
Asciminib for chronic myeloid leukaemia – chronic phase -third line	Asciminib (ABL001)	Chronic myeloid leukaemia (CML)	Haematological Cancer and Lymphomas	2020	View \| Download
ATB200/AT2221 for Late onset Pompe disease in adults and adolescents over 12 years – first line	ATB200/AT2221	Pompe disease	Endocrine Nutritional and Metabolic Disorders , Genetic Disorders	2020	View \| Download